SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense bullish momentum as investors re-rate the company from a cyclical manufacturer to a foundational player in the AI infrastructure supercycle, driven by persistent supply shortages and explosive demand for high-bandwidth memory. While the community is actively debating the sustainability of this parabolic move, much of the discourse focuses on supply constraints, long-term earnings potential, and the divergence between current valuations and the massive scaling of AI data centers.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is seeing significant market momentum driven by a strong quarterly earnings report that highlighted the expansion of its Matrix-M adjuvant technology into over 30 oncology and infectious disease fields. While community sentiment is divided between optimism over potential strategic partnerships and frustration regarding executive compensation, shares are rallying as traders speculate on the firm's role in the vaccine landscape and potential future buyouts.

Aventus Network

Aventus Network is currently trending as the community highlights its low market capitalization, Polkadot integration, and recent strategic advisory appointments in the UAE as potential catalysts for a breakout. Traders are actively debating its enterprise-grade utility, with many expressing interest in its long-term potential while closely monitoring trading volume for signs of a sustained move.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant market interest driven by ongoing momentum in its mRNA oncology platform and promising clinical data from its flu and combination vaccine programs, which are currently being presented at major industry events. The community remains focused on the company's efforts to expand beyond COVID-19, with active discussions surrounding potential clinical readouts, institutional accumulation, and the stock's position as a high-beta biotech play with strong short-interest dynamics.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is rallying on investor optimism surrounding a major colocation deal with Cerebras Systems, which investors see as a strategic proxy play for the upcoming Cerebras IPO. The community is actively debating the stock's valuation upside and potential re-rating as a key AI infrastructure provider, despite ongoing discussions about capital management and share offerings.

NovaChargeX Coin (NCX) is an Ethereum-based ERC-20 token connected to NovaChargeX LLC, a clean-energy company developing patented hybrid regenerative power systems designed to deliver continuous, grid-independent electricity. The token serves as the on-chain entry point to the NovaChargeX ecosystem, linking blockchain participants to a real-world infrastructure project focused on supplying 24/7 power to AI data centers, industrial facilities, and other operations that cannot tolerate downtime. NCX is positioned in the real-world asset (RWA) and clean-energy infrastructure category. The parent company has been recognized by the World Future Awards 2025 for Best Hybrid Regenerative Clean Energy System and has received coverage from Al Arabiya English, SolarQuarter, and Reuters. The token contract is deployed on Ethereum mainnet, ownership has been renounced, and a third-party security audit has been completed.

NovaChargeX Coin

NovaChargeX is capturing investor attention by positioning itself at the intersection of clean energy infrastructure, blockchain utility, and real-world asset integration. Community members are actively discussing the project's patented technology and its potential to address growing AI-related power demands while remaining in an early development stage.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

Investors are actively debating the Fundrise Innovation Fund's massive premium over its net asset value, with some seeing the exposure to high-profile private AI and tech companies as a generational opportunity while others warn of significant downside risk from insider share sales. Community sentiment is deeply divided, as traders oscillate between celebrating the ticker's explosive volatility and expressing frustration over the lack of transparency and speculative price swings.

Julong Holding Ltd. engages in the business of investment holding activities. It provides intelligent integrated solutions to public utilities, enterprises, commercial, and multifamily properties. The company was founded by Jia Qi Hu on August 07, 2023 and is headquartered in Beijing, China.

Julong Holding Ltd. - Ordinary Shares - Class A

Julong Holding Ltd. ($JLHL) is trending as retail investors circulate comparisons to previous low-float Chinese stocks that experienced parabolic rallies, fueling speculation that this ticker may see a similar short squeeze. The community is focused on the stock's extremely thin effective float and high insider ownership, with traders actively monitoring level 2 data and volatility pauses in hopes of a rapid upward move.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is trending as retail and institutional investors pile into the stock, driven by a narrative that its specialized MRAM memory technology is essential for the future of edge AI and space-hardened infrastructure. The community is actively discussing its potential for a massive short squeeze due to its low float and perceived sympathy with broader semiconductor and memory market momentum.

The KARRAT protocol is a decentralized gaming infrastructure layer, supported by $KARRAT and empowered by a truly decentralized community with a shared vision embracing gaming, entertainment and AI products catering for the new era.  To accelerate the evolution of gaming, entertainment, and AI-driven experiences with blockchain technology and a truly empowered community.  The KARRAT protocol pioneers a decentralized framework in gaming and entertainment, combining blockchain with community-driven collaboration. $KARRAT can animate ecosystems of games and products and the protocol makes tools available to support these industries and the adoption of KARRAT technology provides a unique, personalized gaming experience.

KARRAT

KARRAT is gaining traction as investors anticipate a major breakout, driven by its strategic positioning in the Web3 gaming sector and infrastructure integrations like StudioChain. The community is actively discussing potential explosive growth, with many traders accumulating tokens while debating the project's technical setup and long-term potential against a backdrop of broader altcoin market sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Estrella Immunopharma to Participate in the D. Boral Capital Global Conference

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) (Estrella or the Company), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancer and...

Short Interest in Estrella Immunopharma, Inc. (NASDAQ:ESLA) Declines By 57.6%

Estrella Immunopharma, Inc. (NASDAQ:ESLA - Get Free Report) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totaling 265,805 shares, a decrease of 57.6% from the March 31st total of 626,324 shares. Based on an average...

Estrella Immunopharma (NASDAQ:ESLA) Trading Up 26.5% - Here's Why

Estrella Immunopharma (NASDAQ:ESLA) Shares Up 26.5% - Here's What Happened...

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research

D. Boral Capital Reiterates Buy Rating for Estrella Immunopharma (NASDAQ:ESLA)

D. Boral Capital reissued a "buy" rating and issued a $8.00 price target on shares of Estrella Immunopharma in a research report on Monday...

Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT & CIBMTR

Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW) (Estrella or the Company), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancer and...

Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem Meetings of ASTCT & CIBMTR

Estrella Immunopharma, Inc. (Nasdaq: ESLA) (Estrella or the Company), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancer and...

Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Estrella Immunopharma, Inc. (NASDAQ: ESLA) (the Company), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancers and autoimmune...

Short Interest in Estrella Immunopharma, Inc. (NASDAQ:ESLA) Grows By 28.5%

Estrella Immunopharma, Inc. (NASDAQ:ESLA - Get Free Report) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 709,318 shares, an...

Estrella Immunopharma (NASDAQ:ESLA) Trading 1.3% Higher - Here's Why

Estrella Immunopharma (NASDAQ:ESLA) Trading 1.3% Higher - What's Next...

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.

Estrella Immunopharma Inc

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Current Price	$1.26
Prev Close	$1.27
Open	$1.25
Dividend Yield	0.00%
50-Day Moving Average	$1.37
Beta	0.75
Avg. Volume	165,642.40
PE Ratio	-3.53

52-Week High	$3.15
52-Week Low	$0.78
Market Capitalization	$53.76M
EPS (Annual)	-$0.3548
Price to Book	-4.62
Revenue Per Employee	N/A

ESLA
Estrella Biopharma Inc

Feed

News

Sentiment

Fundamentals

Info

Latest ESLA News

ESLAEstrella Biopharma Inc